Myasthenia gravis is caused by autoantibodies against postsynaptic nicotinic ACh receptors, progressively reducing the number of functional receptors and producing fatigable weakness that worsens with repeated use — in contrast to Lambert-Eaton myasthenic syndrome, which targets presynaptic voltage-gated calcium channels and characteristically improves with repeated activity.